Global Blood Therapeutics... (GBT)

AI Score

Unlock

68.49

0.01 (0.01%)

At close: Oct 04, 2022, 8:00 PM

Global Blood Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	71.55M	55.16M	56.1M	52.05M	47.55M	39.04M	41.3M	36.89M	31.5M	14.12M	2.11M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	1.41M	1.05M	1.15M	830K	748K	584K	961K	513K	377K	135K	48K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	70.14M	54.1M	54.95M	51.22M	46.81M	38.46M	40.33M	36.38M	31.12M	13.98M	2.06M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-73.88M	-73.05M	-83.19M	-67.29M	-66.07M	-71.36M	-59.37M	-58.31M	-52.04M	-73.45M	-99.22M	-68.74M	-60.8M	-52.52M	-52.08M	-45.48M	-42.49M	-42.7M	-41.91M	-29.18M	-24.43M	-23.72M	-27.46M	-21.14M	-17.81M	-16.72M
Interest Income	1.66M	500K	142K	85K	164K	329K	583K	881K	1.51M	2.86M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-248K	n/a	131K	117K
Pretax Income	-82.28M	-81.25M	-87.1M	-70.99M	-69.59M	-74.93M	-61.81M	-59.88M	-52.84M	-73.03M	-95.97M	-64.55M	-57.32M	-48.92M	-49.2M	-43.07M	-40.37M	-41.56M	-41.25M	-28.56M	-23.88M	-23.33M	-27.21M	-20.98M	-17.68M	-16.6M
Net Income	-82.47M	-81.42M	-91.5M	-70.99M	-69.59M	-74.93M	-61.81M	-59.88M	-52.84M	-73.03M	-95.97M	-64.55M	-57.32M	-48.92M	-49.2M	-43.07M	-40.37M	-41.56M	-41.25M	-28.56M	-23.88M	-23.33M	-27.21M	-20.98M	-17.68M	-16.6M
Selling & General & Admin	81.09M	74.53M	78.94M	67.99M	61.09M	58.97M	59.62M	54.49M	49.08M	47.66M	44.59M	29.65M	24.79M	18.05M	15.32M	12.45M	10.91M	12.75M	10.62M	8.23M	6.15M	6.44M	7.09M	6M	4.52M	4.3M
Research & Development	64.78M	52.83M	58.97M	50.53M	51.78M	50.86M	41.07M	40.2M	34.09M	39.77M	64.99M	39.09M	36.01M	34.47M	36.76M	33.03M	31.57M	29.94M	31.29M	20.95M	18.28M	17.28M	20.36M	15.14M	13.29M	12.41M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	145.86M	127.37M	137.91M	118.52M	112.88M	109.82M	100.69M	94.69M	83.16M	87.44M	109.58M	68.74M	60.8M	52.52M	52.08M	45.48M	42.49M	42.7M	41.91M	29.18M	24.43M	23.72M	27.46M	21.14M	17.81M	16.72M
Interest Expense	8.4M	8.21M	4.39M	3.71M	3.68M	3.69M	2.92M	2.29M	2.28M	2.31M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	159K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	-37.11M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	147.28M	128.42M	139.06M	119.35M	113.63M	110.41M	101.65M	95.2M	83.54M	87.57M	109.63M	68.74M	60.8M	52.52M	52.08M	45.48M	42.49M	42.7M	41.91M	29.18M	24.43M	23.72M	27.46M	21.14M	17.81M	16.72M
Income Tax Expense	192K	171K	4.39M	15K	155K	123K	490K	721K	1.48M	2.74M	3.24M	4.2M	3.48M	3.6M	2.88M	2.41M	2.12M	1.14M	663K	623K	547K	389K	252K	159K	131K	117K
Shares Outstanding (Basic)	65.59M	64.84M	64.49M	62.93M	62.31M	62.1M	61.85M	61.57M	61.12M	60.79M	60.35M	60.1M	56.54M	56.23M	52.97M	52.05M	51.74M	47.77M	43.81M	43.26M	43.06M	39.13M	36.58M	36.35M	30.38M	29.44M
Shares Outstanding (Diluted)	65.59M	64.84M	64.49M	62.93M	62.31M	62.1M	61.85M	61.57M	61.12M	60.79M	60.35M	60.1M	56.54M	56.23M	52.97M	52.05M	51.74M	47.77M	43.81M	43.26M	43.06M	39.13M	36.58M	36.35M	30.38M	29.44M
EPS (Basic)	-1.26	-1.26	-1.42	-1.13	-1.12	-1.21	-1	-0.97	-0.86	-1.2	-1.59	-1.07	-1.01	-0.87	-0.93	-0.83	-0.78	-0.87	-0.94	-0.66	-0.55	-0.6	-0.74	-0.58	-0.58	-0.56
EPS (Diluted)	-1.26	-1.26	-1.42	-1.13	-1.12	-1.21	-1	-0.97	-0.86	-1.2	-1.59	-1.07	-1.01	-0.87	-0.93	-0.83	-0.78	-0.87	-0.94	-0.66	-0.55	-0.6	-0.74	-0.58	-0.58	-0.56
EBITDA	-71.57M	-70.78M	-80.97M	-65.09M	-63.75M	-69.2M	-55.89M	-55.92M	-47.33M	-67.78M	-92.67M	-62.32M	-55.12M	-46.73M	-47.1M	-41.9M	-39.7M	-40.89M	-40.6M	-28.16M	-23.79M	-22.82M	-26.81M	-20.66M	-17.4M	-16.36M
EBIT	-73.88M	-73.05M	-82.71M	-67.28M	-65.92M	-71.24M	-58.88M	-57.59M	-50.56M	-70.71M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-20.83M	n/a	n/a
Depreciation & Amortization	2.31M	2.27M	2.22M	2.19M	2.17M	2.04M	3M	1.67M	3.23M	2.93M	3.31M	2.23M	2.21M	2.19M	2.1M	1.17M	672K	670K	650K	400K	91K	517K	394K	321K	278K	242K